Literature DB >> 35251326

Role of hTERT rs2736100 in pathological scarring.

Roxana Flavia Ilieș1, Salomea-Ruth Halmagyi1, Andreea Cătană1,2, Casian Simon Aioanei1, Istvan Lukacs3, Reka-Eniko Tokes3, Ioana Cristina Rotar3,4, Ioan Victor Pop1.   

Abstract

Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/m2 was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  RT-PCR; atrophic scar; hTERT; hypertrophic scar; single nucleotide polymorphism

Year:  2022        PMID: 35251326      PMCID: PMC8892623          DOI: 10.3892/etm.2022.11186

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

1.  Prevalence of hypertrophic scar formation and its characteristics among the Chinese population.

Authors:  Cecilia W P Li-Tsang; Joy C M Lau; Chetwyn C H Chan
Journal:  Burns       Date:  2005-04-02       Impact factor: 2.744

2.  Going into surgery: Risk factors for hypertrophic scarring.

Authors:  Lisolette Butzelaar; Ezgi A Soykan; Francisca Galindo Garre; Robert H J Beelen; Magda M Ulrich; Frank B Niessen; Aebele B Mink van der Molen
Journal:  Wound Repair Regen       Date:  2015-06-24       Impact factor: 3.617

Review 3.  Effective treatments of atrophic acne scars.

Authors:  Maya Valeska Gozali; Bingrong Zhou
Journal:  J Clin Aesthet Dermatol       Date:  2015-05

Review 4.  Telomeres, lifestyle, cancer, and aging.

Authors:  Masood A Shammas
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-01       Impact factor: 4.294

5.  Treatment of hypertrophic scars and keloids with a fractional CO2 laser: a personal experience.

Authors:  Luca Scrimali; Giuseppe Lomeo; Corrado Nolfo; Gianluca Pompili; Serena Tamburino; Alexei Catalani; Paolo Siragò; Rosario Emanuele Perrotta
Journal:  J Cosmet Laser Ther       Date:  2010-10       Impact factor: 2.247

6.  Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts.

Authors:  Guangzao Li; Renpeng Zhou; Qi Zhang; Banghong Jiang; Qingkai Wu; Chen Wang
Journal:  Exp Cell Res       Date:  2016-05-17       Impact factor: 3.905

Review 7.  Aktuelle Optionen zur Behandlung pathologischer Narben.

Authors:  Julian Poetschke; Gerd G Gauglitz
Journal:  J Dtsch Dermatol Ges       Date:  2016-05       Impact factor: 5.584

8.  Smoking and its effect on scar healing.

Authors:  A E K Deliaert; E Van den Kerckhove; S Tuinder; S M J S Noordzij; T S Dormaar; R R W J van der Hulst
Journal:  Eur J Plast Surg       Date:  2012-01-03

Review 9.  Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.

Authors:  Ricardo Leão; Joana Dias Apolónio; Donghyun Lee; Arnaldo Figueiredo; Uri Tabori; Pedro Castelo-Branco
Journal:  J Biomed Sci       Date:  2018-03-12       Impact factor: 8.410

10.  Telomere shortening may be associated with human keloids.

Authors:  Bruna De Felice; Robert R Wilson; Massimo Nacca
Journal:  BMC Med Genet       Date:  2009-10-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.